Covalon Technologies Ltd. (the "Company" or "Covalon") (COV.V), an advanced medical technologies company, today announced that it will be exhibiting for the first time at the 32nd Annual Oley Consumer/Clinician Conference taking place at the Hyatt Regency in Old Greenwich, CT from July 5-8, 2017.
In addition to exhibiting, Covalon will sponsor a presentation by Brenda Gray, PharmD, CNSC, BCNSP, PRS CVAA(c) entitled Medical Adhesive-Related Skin Injuries (MARSI), how consumers can prevent and manage its occurrence on July 7, 2017 at 2:45pm and 4pm in Salon Cos Cob.
Medical adhesive-related skin injury is a clinically relevant and potentially avoidable event. Preventing MARSI has the potential to reduce complications, increase patient satisfaction, and improve clinical outcomes.1
Covalon’s IV Clear™ is indicated to cover and protect vascular access devices used in a wide variety of both acute and alternate care settings. Its patented combination of chlorhexidine and silver is proven to have a synergistic effect against some of the most commonly associated blood stream infection bacteria2 and its skin sparing silicone adhesive will not cause adhesive related skin injury or pain during dressing changes3.
“As proud first time sponsors of this event, and are excited about the opportunity to show patients and their clinicians the combined benefits that only IV Clear can offer,” said John R. Hands, Executive Vice President.
The Oley Foundation is a national, independent, non-profit organization that strives to enrich the lives of patients dependent on home intravenous nutrition (parenteral) and tube feeding (enteral) through education, advocacy, and networking. The Foundation also serves as a resource for consumer’s families, clinicians and industry representatives, and other interested parties.
To learn more about IV Clear, visit Covalon at booth 23 during exhibit hours, or email ivclear@covalon.com
About Covalon
Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies that help save lives around the world. Covalon's patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Covalon's technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility. To learn more about Covalon, visit our website at www.covalon.com
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854
